Novascan Inc
Novascan Inc, based in Chicago, IL, is a clinical-stage oncology company dedicated to improving cancer detection and stratification through its innovative platform technology. Their flagship product, MarginScan, offers dermatologists a fast and reliable method for assessing healthy tissue during skin cancer procedures, enhancing patient outcomes and reducing healthcare costs.
Committed to advancing cancer diagnosis, Novascan's technologies provide instantaneous and highly accurate results without the need for capital equipment, making them suitable for both ex vivo and in vivo applications. The company is actively involved in clinical trials and has garnered recognition for its groundbreaking devices, including presentations at prominent medical conferences.
Generated from the website